The outlook of companies tied to iconic drugs like Viagra presents a challenging investment picture. While the initial boom of copyright, fueled by Viagra's unprecedented popularity, generated substantial returns, the patent here expiration in key regions has introduced substantial volatility. Investors are now grappling with the effect of generic